![Jennifer Herron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Herron
Director/Board Member at
Gwynedd-Mercy Academy
Profile
Jennifer L.
Herron is a Trustee at Gwynedd-Mercy Academy.
She previously worked as an Independent Director at ChemoCentryx, Inc. and Genocea Biosciences, Inc. She was also the Vice President-US Immunology at Bristol Myers Squibb Co. from 2006 to 2016.
In addition, she served as the Chief Commercial Officer & Executive Vice President at ImmunoGen, Inc. in 2019, and as the President & Executive VP-Global Commercial at MorphoSys AG and Bio-Rad AbD Serotec, Inc. She started her career as an Associate at Boehringer Mannheim Pharmaceuticals Corp.
Ms. Herron's education includes an undergraduate degree from Lehigh University and an MBA from Georgetown University.
Currently, she is a Trustee at Gwynedd-Mercy Academy and the Chief Commercial Officer & Senior Vice President at ADC Therapeutics SA.
Jennifer Herron active positions
| Companies | Position | Start |
|---|---|---|
Gwynedd-Mercy Academy
 Gwynedd-Mercy Academy Other Consumer ServicesConsumer Services Operates as secondary school | Director/Board Member | - |
Former positions of Jennifer Herron
| Companies | Position | End |
|---|---|---|
| ADC THERAPEUTICS SA | Corporate Officer/Principal | 2022-11-16 |
| CHEMOCENTRYX, INC. | Director/Board Member | 2022-10-19 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 2019-02-28 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-03-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2015-12-31 |
Training of Jennifer Herron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Bio-Rad AbD Serotec, Inc.
 Bio-Rad AbD Serotec, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies monoclonal and polyclonal antibodies to the research community | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Mannheim Pharmaceuticals Corp. | |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Gwynedd-Mercy Academy
Gwynedd-Mercy Academy Other Consumer ServicesConsumer Services Operates as secondary school | Consumer Services |
- Stock Market
- Insiders
- Jennifer Herron
